Universitätsklinikum Essen

Modulation of immune responses to liposomal vaccines by intrastructural help (2023) Damm D, Suleiman E, Wagner J, Klessing S, Pfister F, Elsayed H, Walkenfort B, et al. Journal article S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care (2023) Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article How familiar are German dermatologists with placebo and nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological community (2023) Krefting F, Hölsken S, Benson S, Schedlowski M, Sondermann W Journal article S3-Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen (2023) Heppt M, Steeb T, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) (2023) Kähler KC, Hüning S, Nashan D, Meiss F, Rafei-Shamsabadi DA, Rissmann H, Colapietro C, et al. Journal article Urinary incontinence after radical prostatectomy for prostate cancer-data from 17,149 patients from 125 certified centers (2023) Kowalski C, Sibert NT, Hammerer P, Wesselmann S, Feick G, Carl EG, Klotz T, et al. Journal article Palliativmedizin in onkologischen Spitzenzentren (2023) Gahr S, Berendt J, Tewes M Journal article Design and Implementation of an ETL-Process to Transfer Wound-Related Data into a Standardized Common Data Model (2023) Przysucha M, Hüsers J, Liberman D, Kersten O, Schlüter A, Fraas S, Busch D, et al. Book chapter / Article in edited volumes Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (2023) Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al. Journal article Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (Nature Cancer, (2023), 4, 9, (1292-1308), 10.1038/s43018-023-00610-2) (2023) Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al. Journal article, Erratum